News Chart NFL Biosciences

Stocks

ALNFL

FR0014003XT0

Biotechnology & Medical Research

Real-time Euronext Paris 03:00:19 2026-08-26 EDT			5-day change	1st Jan Change
0.8900 ^EUR	-0.56%		+2.53%	-24.45%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI

8087e82d33d7df1cfb723e015f.mVvbgVarWjeQm4hcdbuLPSOwCmEbqmbExyPP8IVVLg0.9iPosDzIC3X54e0bE-rxWWTBYRtd7Auz9EWWg8FmHD-gI4-1ZNM5Gv2i3Q~37763d10726e9fa8b12839ba64f30d4d